← All organizations
Kowa
Also known as: IMAGE TECHNOLOGIES INC. | KOWA CO | Kowa Company, Ltd. | Kowa Pharmaceuticals America, Inc. | Kowa Pharma Development Co. | KOWA PHARMS | Kowa Research Europe | Kowa Research Europe (KRE) | Kowa Research Institute, Inc.
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2005First marketed drug
Aug 3, 2009First NDA
Aug 3, 2009Last known activity
Oct 1, 2024
Timeline
1890s
- Jan 1, 1894
Kowa— Founded
2000s
- Aug 4, 2008
ProEthic Pharmaceuticals— Acquired
- Aug 3, 2009
pitavastatin— NDA Organization
2020s
- Oct 15, 2021
celecoxib— NDA Secondary Org
Drugs by trial phase (48 distinct, 77 trials)
Phase 4 (13 own, 0 via acquisition)
Phase 3 (10 own, 1 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (11 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Approved for
Studied for
- Acute Pain
- Ankle Injuries
- Atherosclerosis
- Cardiovascular Diseases
- Corneal Dystrophies, Hereditary
- Coronary Artery Disease
- Coronary Disease
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Retinopathy
- Dry Eye Syndromes
- Dyslipidemias
- Eye Diseases
- Fatty Liver
- Fuchs' Endothelial Dystrophy
- Heart Diseases
- Hypercholesterolemia
- Hyperlipidemias
- Hyperlipoproteinemias
- Hypertriglyceridemia
- Intermittent Claudication
- Iridocorneal Endothelial Syndrome
- Keratoconjunctivitis Sicca
- Liver Diseases
- Liver Neoplasms
- Macular Edema
- Metabolic Syndrome
- Myalgia
- Myocardial Ischemia
- Neoplasms
- Non-alcoholic Fatty Liver Disease
- Recurrence
- Renal Insufficiency
- Retinal Diseases
- Sprains and Strains
- Syndrome
Marketed drugs (3)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (50)
- NCT06525311Lead sponsorPhase 1Oct 1, 2024
- NCT06525311OfficialPhase 1Oct 1, 2024
- NCT06247735Lead sponsorPhase 2Feb 7, 2024
- NCT06247735OfficialPhase 2Feb 7, 2024
- NCT05826353Lead sponsorPhase 3May 11, 2023
- NCT05826353Study chairPhase 3May 11, 2023
- NCT05923281Lead sponsorPhase 3May 1, 2023
- NCT05795699Study chairPhase 3Mar 30, 2023
- NCT05795699Lead sponsorPhase 3Mar 30, 2023
- NCT05722262Lead sponsorPhase 1Feb 24, 2023
- NCT05327127Lead sponsorPhase 2Nov 14, 2022
- NCT05327127Study chairPhase 2Nov 14, 2022
- NCT05528172Lead sponsorPhase 3Aug 4, 2022
- NCT05528172Study chairPhase 3Aug 4, 2022
- NCT05403827Lead sponsorPhase 3Jul 3, 2022
Details
- Founded
- Nagoya, JP Jan 1, 1894
- First NDA
- Aug 3, 2009
- Last known activity
- Oct 1, 2024